Piedmont Athens Regional Medical Center has earned recognition from U.S. News & World Report on the publication’s 2018-19 Honor Roll of the Best Hospitals...
Data from the TRANSITION study presented at the European Society of Cardiology (ESC) Congress in Munich, Germany has shown that Entresto® (sacubitril/valsartan) can be...
VolitionRx Limited announced preliminary data from a prospective, multi-centered Proof of Concept Study of 84 men into the utility of Volition's Nu.Q™ assays to...
VolitionRx Limited announced financial results and a business update for the quarter ended June 30, 2018. Volition management will host a conference call to...
SPR Therapeutics, Inc., a leader in neurostimulation technology for pain, announced that the U.S. FDA has cleared its SPRINT® endura™ (single lead) and extensa™...
We use cookies to give you the best experience. By continuing to use this site you consent to the use of cookies, unless disabled from your browser. OkCookie Policy
